Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Submitted by
admin
on December 9, 2012 - 1:21pm
Source:
Motley Fool
News Tags:
Chelsea Therapeutics
Cell Therapeutics
Aeterna Zentaris
Progenics Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Headline:
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Do Not Allow Advertisers to Use My Personal information
